Trials / Completed
CompletedNCT02906254
Early Antibiotic Discontinuation in FUO
Early Discontinuation of Empirical Antibacterial Therapy in Febrile Neutropenia: Prospective Observational Study (ANTIBIOSTOP)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 123 (actual)
- Sponsor
- University Hospital, Brest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Febrile neutropenia requires prompt initiation of broad-spectrum antibiotics, which can be responsible for side-effects and selection of resistance. This study demonstrates the safety of an early discontinuation of empirical treatments, in carefully selected patients presenting with fever of unknown origin.
Detailed description
Infections are responsible for significant morbidity and mortality in haematological patients, in particular during chemotherapy-induced neutropenia. Guidelines recommend immediate initiation of antibiotic therapy, whose optimal duration is unclear. The primary objective of this study is to evaluate early discontinuation of antibiotic treatment for Fever of Unknown Origin (FUO) in afebrile or febrile neutropenic patients. The secondary objective is to describe the epidemiology of febrile neutropenia (FN) in investigator centre. Every episode of FN was prospectively identified. In the first phase of the study, empirical antibiotic therapy of FUO patients was stopped after 48 hours of apyrexia, in accordance with ECIL-4 (European Conference on Infections in Leukaemia) recommendations. In the second phase of the study, antibiotics were stopped on day 5 for all FUO patients, regardless of their temperature or their leukocyte count.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | ECIL-4 guidelines group | Antibiotics were stopped when patients had been afebrile for more than 48 hours |
| OTHER | Short-course antibiotic therapy | Antibiotics were stopped on day 5 in febrile or afebrile patients |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2016-09-20
- Last updated
- 2016-09-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02906254. Inclusion in this directory is not an endorsement.